Homoeopathic medicines
ApprovedSmall molecule
Homoeopathic medicines is one of 52 small molecule programs targeting Female Infertility. It is currently in Approved.
2
Indications
3
Total Trials
0
Active Trials
51
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
160 competitors in Autism Spectrum Disorder
#DrugCompanyPhaseTrials
1Vraylar
AbbViePhase 3
Elavil
AstraZenecaPhase 3
Bumex
VValidus Pharmaceuticals
Phase 3
Rexulti
OtsukaPhase 3
Nuplazid
AACADIA Pharmaceuticals Inc.
Phase 3
Glucophage
EMD SeronoPhase 3
Lithobid
SSolvay Pharmaceuticals
Phase 3
Hetlioz
VVanda Pharmaceuticals
Phase 3
Circadin
NNeurim Pharmaceuticals Ltd.
Phase 3
Karx-EC
Bristol-Myers SquibbPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Autism Spectrum Disorder1 trial
RCT1 trial
Pilot RCT Using Homeopathic Medicines in ASD
Completed·—·Phase 4·NCT07161804·54 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Homoeopathic medicines. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details